Cardiovascular risk in chronic autoimmune thyroiditis and subclinical hypothyroidism patients. A cluster analysis

Giovanni Carbotta, Francesco Tartaglia, Alessandro Giuliani, Sabino Carbotta, Luciana Tromba, Ilaria Jacomelli, Livia De Anna, Angela Fumarola

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background Subclinical hypothyroidism (SCH) and chronic autoimmune thyroiditis (CAT) are linked to an increased risk of atherosclerosis and coronary heart disease (CHD). The aim of this study was to look for positive markers of CHD and correlations with thyroid blood tests in patients with SCH or CAT, but no symptoms of CHD, so as to identify CHD risk conditions that otherwise would likely be missed. Methods We measured a series of thyroid, clinical-metabolic and cardiovascular parameters in 30 consecutive endocrinology patients enrolled in our ambulatory endocrinological referral center of “Sapienza” University of Rome. (19 with CAT, 11 with SCH) from January 2015 to March 2015. 13 asymptomatic subjects were enrolled as controls. In each patient, we measured a series of 34 thyroid, clinical-metabolic and cardiovascular parameters. Results in the statistical analysis of collected data, the oblique principal components clustering procedure (OPC) revealed the presence of an interesting mixed cluster, composed of a thyroid parameter (TPO-Ab), a metabolic parameter (homocysteine level) and a cardiovascular parameter (MAPSE), in which we assessed the relationships between the single components. Our preliminary results indicate that in both groups of patients elevated TPO-Ab, when accompanied by reduced MAPSE and increased IMT and homocysteine values, may be taken to indicate the presence of clinically unrecognized CHD. Conclusions Confirmation of these results in larger series of patients could justify hormone therapy for prevention of CHD in these thyroid patients versus placebo treatment.

Original languageEnglish
Pages (from-to)115-119
Number of pages5
JournalInternational Journal of Cardiology
Volume230
DOIs
Publication statusPublished - Mar 1 2017

Fingerprint

Autoimmune Thyroiditis
Hypothyroidism
Coronary Disease
Cluster Analysis
Thyroid Gland
Homocysteine
Statistical Data Interpretation
Endocrinology
Hematologic Tests
Chronic Thyroiditis
Atherosclerosis
Referral and Consultation
Placebos
Hormones
Therapeutics

Keywords

  • Cardiovascular risk
  • Chronic autoimmune thyroiditis
  • Echo-color Doppler
  • L-Thyroxine therapy
  • Subclinical hypothyroidism

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cardiovascular risk in chronic autoimmune thyroiditis and subclinical hypothyroidism patients. A cluster analysis. / Carbotta, Giovanni; Tartaglia, Francesco; Giuliani, Alessandro; Carbotta, Sabino; Tromba, Luciana; Jacomelli, Ilaria; De Anna, Livia; Fumarola, Angela.

In: International Journal of Cardiology, Vol. 230, 01.03.2017, p. 115-119.

Research output: Contribution to journalArticle

Carbotta, Giovanni ; Tartaglia, Francesco ; Giuliani, Alessandro ; Carbotta, Sabino ; Tromba, Luciana ; Jacomelli, Ilaria ; De Anna, Livia ; Fumarola, Angela. / Cardiovascular risk in chronic autoimmune thyroiditis and subclinical hypothyroidism patients. A cluster analysis. In: International Journal of Cardiology. 2017 ; Vol. 230. pp. 115-119.
@article{984f0195e7474865b4849f9a0fb6ddf4,
title = "Cardiovascular risk in chronic autoimmune thyroiditis and subclinical hypothyroidism patients. A cluster analysis",
abstract = "Background Subclinical hypothyroidism (SCH) and chronic autoimmune thyroiditis (CAT) are linked to an increased risk of atherosclerosis and coronary heart disease (CHD). The aim of this study was to look for positive markers of CHD and correlations with thyroid blood tests in patients with SCH or CAT, but no symptoms of CHD, so as to identify CHD risk conditions that otherwise would likely be missed. Methods We measured a series of thyroid, clinical-metabolic and cardiovascular parameters in 30 consecutive endocrinology patients enrolled in our ambulatory endocrinological referral center of “Sapienza” University of Rome. (19 with CAT, 11 with SCH) from January 2015 to March 2015. 13 asymptomatic subjects were enrolled as controls. In each patient, we measured a series of 34 thyroid, clinical-metabolic and cardiovascular parameters. Results in the statistical analysis of collected data, the oblique principal components clustering procedure (OPC) revealed the presence of an interesting mixed cluster, composed of a thyroid parameter (TPO-Ab), a metabolic parameter (homocysteine level) and a cardiovascular parameter (MAPSE), in which we assessed the relationships between the single components. Our preliminary results indicate that in both groups of patients elevated TPO-Ab, when accompanied by reduced MAPSE and increased IMT and homocysteine values, may be taken to indicate the presence of clinically unrecognized CHD. Conclusions Confirmation of these results in larger series of patients could justify hormone therapy for prevention of CHD in these thyroid patients versus placebo treatment.",
keywords = "Cardiovascular risk, Chronic autoimmune thyroiditis, Echo-color Doppler, L-Thyroxine therapy, Subclinical hypothyroidism",
author = "Giovanni Carbotta and Francesco Tartaglia and Alessandro Giuliani and Sabino Carbotta and Luciana Tromba and Ilaria Jacomelli and {De Anna}, Livia and Angela Fumarola",
year = "2017",
month = "3",
day = "1",
doi = "10.1016/j.ijcard.2016.12.066",
language = "English",
volume = "230",
pages = "115--119",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Cardiovascular risk in chronic autoimmune thyroiditis and subclinical hypothyroidism patients. A cluster analysis

AU - Carbotta, Giovanni

AU - Tartaglia, Francesco

AU - Giuliani, Alessandro

AU - Carbotta, Sabino

AU - Tromba, Luciana

AU - Jacomelli, Ilaria

AU - De Anna, Livia

AU - Fumarola, Angela

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Background Subclinical hypothyroidism (SCH) and chronic autoimmune thyroiditis (CAT) are linked to an increased risk of atherosclerosis and coronary heart disease (CHD). The aim of this study was to look for positive markers of CHD and correlations with thyroid blood tests in patients with SCH or CAT, but no symptoms of CHD, so as to identify CHD risk conditions that otherwise would likely be missed. Methods We measured a series of thyroid, clinical-metabolic and cardiovascular parameters in 30 consecutive endocrinology patients enrolled in our ambulatory endocrinological referral center of “Sapienza” University of Rome. (19 with CAT, 11 with SCH) from January 2015 to March 2015. 13 asymptomatic subjects were enrolled as controls. In each patient, we measured a series of 34 thyroid, clinical-metabolic and cardiovascular parameters. Results in the statistical analysis of collected data, the oblique principal components clustering procedure (OPC) revealed the presence of an interesting mixed cluster, composed of a thyroid parameter (TPO-Ab), a metabolic parameter (homocysteine level) and a cardiovascular parameter (MAPSE), in which we assessed the relationships between the single components. Our preliminary results indicate that in both groups of patients elevated TPO-Ab, when accompanied by reduced MAPSE and increased IMT and homocysteine values, may be taken to indicate the presence of clinically unrecognized CHD. Conclusions Confirmation of these results in larger series of patients could justify hormone therapy for prevention of CHD in these thyroid patients versus placebo treatment.

AB - Background Subclinical hypothyroidism (SCH) and chronic autoimmune thyroiditis (CAT) are linked to an increased risk of atherosclerosis and coronary heart disease (CHD). The aim of this study was to look for positive markers of CHD and correlations with thyroid blood tests in patients with SCH or CAT, but no symptoms of CHD, so as to identify CHD risk conditions that otherwise would likely be missed. Methods We measured a series of thyroid, clinical-metabolic and cardiovascular parameters in 30 consecutive endocrinology patients enrolled in our ambulatory endocrinological referral center of “Sapienza” University of Rome. (19 with CAT, 11 with SCH) from January 2015 to March 2015. 13 asymptomatic subjects were enrolled as controls. In each patient, we measured a series of 34 thyroid, clinical-metabolic and cardiovascular parameters. Results in the statistical analysis of collected data, the oblique principal components clustering procedure (OPC) revealed the presence of an interesting mixed cluster, composed of a thyroid parameter (TPO-Ab), a metabolic parameter (homocysteine level) and a cardiovascular parameter (MAPSE), in which we assessed the relationships between the single components. Our preliminary results indicate that in both groups of patients elevated TPO-Ab, when accompanied by reduced MAPSE and increased IMT and homocysteine values, may be taken to indicate the presence of clinically unrecognized CHD. Conclusions Confirmation of these results in larger series of patients could justify hormone therapy for prevention of CHD in these thyroid patients versus placebo treatment.

KW - Cardiovascular risk

KW - Chronic autoimmune thyroiditis

KW - Echo-color Doppler

KW - L-Thyroxine therapy

KW - Subclinical hypothyroidism

UR - http://www.scopus.com/inward/record.url?scp=85009343970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009343970&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2016.12.066

DO - 10.1016/j.ijcard.2016.12.066

M3 - Article

C2 - 28038798

AN - SCOPUS:85009343970

VL - 230

SP - 115

EP - 119

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -